v3.26.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
REVENUE:    
Total revenue $ 367 $ 211,246
OPERATING EXPENSES:    
Research and development (16,097) (48,709)
General and administrative (10,147) (10,497)
Total operating expenses (26,244) (59,206)
INCOME (LOSS) FROM OPERATIONS (25,877) 152,040
OTHER INCOME (EXPENSE), NET    
Dividend income 2,335 6,792
Other expense, net (166) (338)
Total other income, net 2,169 6,454
Income (loss) before income taxes (23,708) 158,494
Income tax provision 0 (10,043)
Net income (loss) (23,708) 148,451
Net income (loss) attributable to common stockholders - basic (23,708) 148,451
Net income (loss) attributable to common stockholders - diluted $ (23,708) $ 148,451
Weighted average shares of common stock outstanding - Basic (in shares) 19,629,906 40,559,355
Weighted average shares of common stock outstanding - diluted (in shares) 19,629,906 41,021,325
Net income (loss) per share of common stock - Basic (in USD per share) $ (1.21) $ 3.66
Net income (loss) per share of common stock - Diluted (in USD per share) $ (1.21) $ 3.62
Service and other revenue    
REVENUE:    
Total revenue $ 367 $ 15,891
License revenue    
REVENUE:    
Total revenue $ 0 $ 195,355